Healthcare -
Biotechnology - NASDAQ - US
$ 4.465
-1.22 %
$ 399 M
Market Cap
-10.15
P/E
TRVI - LONG-TERM DEBT
Long-term Debt TRVI - Trevi Therapeutics, Inc.
1.03 M
LAST VALUE
-65.51%
2 YEAR CAGR
-2.01%
5 YEAR CAGR
0.00%
10 YEAR CAGR